Pyrazine derivatives as potential drugs I. by Niklová, Pavlína
Abstract 
Charles University 
Faculty of Pharmacy in Hradec Kralove 
Department of Pharmaceutical Chemistry and Pharmaceutical Analysis 
Author: Pavlína Niklová 
Supervisor: prof. PharmDr. Martin Doležal, Ph.D. 
Title of diploma thesis: Pyrazine Derivatives as Potential Drugs I. 
 
Tuberculosis is serious global problem especially due to its fast resistance 
development to currently used drugs. Therefore drugs used in therapy are only used 
in combinations to avoid any possible complications due to treatment failure. In addition, 
global research is focused on finding new potentially successful drugs with sufficient activity 
against Mycobacterium tuberculosis, main cause of the disease, and acceptable safety, 
therefore suitable for use in TBC therapy. 
Research conducted at the Department of Pharmaceutical Chemistry and 
Pharmaceutical Analysis of Faculty of Pharmacy in Hradec Kralove, Charles University is 
focused on the synthesis of potential new antituberculotics, especially pyrazine derivatives. 
This study deals with the synthesis of five aminopyrazine derivatives by the reaction 
of aminopyrazine with different alkyl substituted isocyanates using microwave reactor. All of 
the synthesized compounds were characterized by their melting point, elementar analysis, 
IR spectra and NMR spectra and then tested in vitro for their antimycobacterial, antibacterial 
and antifungal activities. None of the prepared compounds showed any antibacterial or 
antifungal activity. Also most of them didn’t show any antimycobacterial activity with the 
exception of N-octyl-N'-(pyrazine-2-yl)urea. Its minimum inhibitory concentration against 
M. tuberculosis and M. kansasii was 25 μg/ml. 
 
